Lipocine, Inc. (LPCN)
1.54
+0.01
(+0.65%)
USD |
NASDAQ |
Nov 06, 09:58
Lipocine Price : 1.54 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 1.47 | 1.60 | 1.400 | 1.53 | 417173.0 |
| Nov 04, 2026 | 1.50 | 1.50 | 1.42 | 1.44 | 108129.0 |
| Nov 03, 2026 | 1.42 | 1.50 | 1.42 | 1.46 | 188402.0 |
| Nov 02, 2026 | 1.45 | 1.47 | 1.36 | 1.45 | 248048.0 |
| Oct 30, 2026 | 1.50 | 1.50 | 1.42 | 1.44 | 112049.0 |
| Oct 29, 2026 | 1.51 | 1.56 | 1.50 | 1.52 | 139127.0 |
| Oct 28, 2026 | 1.46 | 1.54 | 1.46 | 1.51 | 194658.0 |
| Oct 27, 2026 | 1.49 | 1.49 | 1.42 | 1.46 | 129469.0 |
| Oct 26, 2026 | 1.44 | 1.45 | 1.40 | 1.45 | 108938.0 |
| Oct 23, 2026 | 1.42 | 1.48 | 1.41 | 1.44 | 218655.0 |
| Oct 22, 2026 | 1.56 | 1.60 | 1.43 | 1.46 | 354883.0 |
| Oct 21, 2026 | 1.59 | 1.64 | 1.581 | 1.60 | 160672.0 |
| Oct 20, 2026 | 1.54 | 1.66 | 1.537 | 1.62 | 246500.0 |
| Oct 19, 2026 | 1.51 | 1.57 | 1.40 | 1.53 | 323657.0 |
| Oct 16, 2026 | 1.66 | 1.68 | 1.48 | 1.56 | 407324.0 |
| Oct 15, 2026 | 1.64 | 1.69 | 1.59 | 1.68 | 267178.0 |
| Oct 14, 2026 | 1.69 | 1.71 | 1.60 | 1.69 | 374292.0 |
| Oct 13, 2026 | 1.64 | 1.74 | 1.61 | 1.62 | 501791.0 |
| Oct 12, 2026 | 1.705 | 1.77 | 1.59 | 1.66 | 884403.0 |
| Oct 09, 2026 | 1.89 | 1.90 | 1.72 | 1.72 | 1.057M |
| Oct 08, 2026 | 2.05 | 2.05 | 1.89 | 1.93 | 2.322M |
| Oct 07, 2026 | 2.95 | 3.15 | 2.07 | 2.20 | 105.84M |
| Oct 06, 2026 | 2.08 | 2.10 | 2.070 | 2.10 | 12778.00 |
| Oct 05, 2026 | 2.07 | 2.135 | 2.07 | 2.07 | 19764.00 |
| Oct 02, 2026 | 2.08 | 2.13 | 2.05 | 2.05 | 38941.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 271.00 |
| ANI Pharmaceuticals, Inc. | 70.50 |
| Corcept Therapeutics, Inc. | 74.16 |
| Veru, Inc. | 2.07 |
| Eli Lilly & Co. | 1372.89 |
Price Related Metrics
| PS Ratio | 6.409 |
| PEG Ratio | -0.0068 |
| Price to Book Value | 0.5833 |
| Earnings Yield | -121.0% |
| Market Cap | 12.70M |
| PEGY Ratio | -0.0068 |